デフォルト表紙
市場調査レポート
商品コード
1534249

慢性創傷治療の世界市場調査レポート:産業分析、規模、シェア、成長、動向、予測(2024年~2032年)

Global Chronic Wound Care Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032


出版日
ページ情報
英文 169 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.73円
慢性創傷治療の世界市場調査レポート:産業分析、規模、シェア、成長、動向、予測(2024年~2032年)
出版日: 2024年07月01日
発行: Value Market Research
ページ情報: 英文 169 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の慢性創傷治療の市場規模は、2023年の177億3,000万米ドルから、2032年には268億8,000万米ドル近くに達し、調査期間2024年~2032年のCAGRは4.73%と推定されます。

慢性創傷治療は、糖尿病、血管疾患、褥瘡などの基礎疾患により、治癒が期待される期間を超えて持続する創傷を治療的に管理するものです。このような創傷は従来の治癒方法に抵抗することが多く、回復を促進し感染症などの合併症を予防するために専門的な治療が必要となるため、大きな課題となります。効果的な創傷治療には、個々の患者のニーズに合わせた包括的なアプローチが必要であり、高度な創傷治療製品、定期的なモニタリング、外科的介入などが組み合わされることが多いです。

市場力学

糖尿病、肥満、心血管疾患などの慢性疾患の世界の蔓延により、慢性創傷管理を必要とする患者層が拡大しています。このような人口動態の変化により、複雑な非治癒性創傷に対応するための先進的な創傷ケア製品や治療法の需要が高まると予想されます。革新的なドレッシング材、生体活性素材、陰圧創傷治療システムなど、創傷治療製品の技術的進歩は治療結果を大きく変えつつあります。これらの技術革新は創傷治癒プロセスを促進し、患者の快適性を向上させ、全体的な治療費を削減するため、慢性創傷治療市場の普及を促進しています。さらに、早期介入と包括的な創傷管理アプローチの利点に対する医療提供者や患者の意識の高まりが市場拡大の原動力となっています。エビデンスに基づいた創傷ケアの実践や高度な創傷ケア技術を活用する利点について臨床医を教育する取り組みが、慢性創傷治療市場の成長をさらに促進しています。さらに、世界人口の高齢化は特に新興経済諸国において大きな市場機会をもたらしています。高齢者は加齢に伴う生理的変化や併存疾患によって慢性創傷を起こしやすいため、高齢者特有のニーズに合わせた専門的な創傷ケアソリューションが必要となります。しかし、先進的な創傷ケア製品や治療法に対する規制上の課題や償還の問題が、慢性創傷治療市場の成長を妨げています。

本調査レポートでは、ポーターのファイブフォースモデル、市場の魅力分析、バリューチェーン分析を取り上げています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは慢性創傷治療の世界市場における各セグメントを包括的に評価することもできます。慢性創傷治療産業の成長と動向は、この調査に全体的なアプローチを提供します。

市場セグメンテーション

慢性創傷治療市場レポートのこのセクションでは、国別および地域別のセグメントに関する詳細なデータを提供し、それによって戦略担当者がそれぞれの製品またはサービスのターゲット層を特定する今後の機会を支援します。

地域分析

本セクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカの地域展望をカバーし、慢性創傷治療市場の現在と将来の需要を明らかにしています。さらに、すべての主要地域における個々の用途セグメントの需要・推定・予測にも焦点を当てています。

カスタム要件がある場合は、お問い合わせください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 慢性創傷治療- 産業分析

  • イントロダクション:市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーのリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 慢性創傷治療の世界市場分析:製品タイプ別

  • 概要:製品タイプ別
  • 実績・予測データ分析:製品タイプ別
  • 先進創傷被覆材(フォームドレッシング、ハイドロコロイドドレッシング、フィルムドレッシング、アルジネートドレッシング、ハイドロゲルドレッシング、コラーゲンドレッシング、その他ドレッシング)
  • 外科用創傷被覆材(縫合糸&ステープル、組織接着剤&シーラント、抗感染性ドレッシング材)
  • 従来型創傷治療(医療用テープ、洗浄剤、その他)
  • 創傷治療デバイス(陰圧創傷治療、酸素・高気圧酸素機器、電気刺激デバイス、圧力除去デバイス、その他)

第6章 慢性創傷治療の世界市場分析:用途別

  • 概要:用途別
  • 実績・予測データ分析:用途別
  • 糖尿病性足潰瘍
  • 褥瘡
  • 静脈性下腿潰瘍
  • その他

第7章 慢性創傷治療の世界市場分析:最終用途別

  • 概要:最終用途別
  • 実績・予測データ分析:最終用途別
  • 病院
  • 専門クリニック
  • 在宅医療
  • その他

第8章 慢性創傷治療の世界市場分析:地域別

  • 地域別展望
  • イントロダクション
  • 北米の売上分析
    • 概要・実績・予測
    • 北米:セグメント別
    • 北米:国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州の売上分析
    • 概要・実績・予測
    • 欧州:セグメント別
    • 欧州:国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋の売上分析
    • 概要・実績・予測
    • アジア太平洋:セグメント別
    • アジア太平洋:国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他アジア太平洋
  • ラテンアメリカの売上分析
    • 概要・実績・予測
    • ラテンアメリカ:セグメント別
    • ラテンアメリカ:国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカの売上分析
    • 概要・実績・予測
    • 中東・アフリカ:セグメント別
    • 中東・アフリカ:国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東・アフリカ

第9章 慢性創傷治療企業の競合情勢

  • 慢性創傷治療市場の競合
  • パートナーシップ/提携/協定
  • 合併・買収
  • 新製品の発売
  • その他の開発

第10章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Johnson & Johnson
  • Baxter International
  • Coloplast Corp.
  • 3M
  • Medline Industries Inc.
  • ConvaTec Group PLC
  • Derma Sciences(Integra LifeSciences)
  • MoLnlycke Health Care AB
  • Paul Hartmann AG
  • Smith & Nephew PLC
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product Type (USD MN)
  • Advanced Wound Dressing (Foam Dressing, Hydrocolloid Dressing, Film Dressing, Alginate Dressing, Hydrogel Dressing, Collagen Dressing, Other Dressing) Market Sales By Geography (USD MN)
  • Surgical Wound Care (Suture & Staples, Tissue Adhesive & Sealants, Anti-Infective Dressing) Market Sales By Geography (USD MN)
  • Traditional Wound Care (Medical Tapes, Cleansing Agents, Others) Market Sales By Geography (USD MN)
  • Wound Therapy Devices (Negative Pressure Wound Therapy, Oxygen and Hyperbaric Oxygen Equipment, Electric Stimulation Devices, Pressure Relief Devices, Others) Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Diabetic Foot Ulcers Market Sales By Geography (USD MN)
  • Pressure Ulcers Market Sales By Geography (USD MN)
  • Venous Leg Ulcers Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By End-use (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Specialty Clinics Market Sales By Geography (USD MN)
  • Home Healthcare Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Chronic Wound Care Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Chronic Wound Care Report
  • Market Research Process
  • Market Research Methodology
  • Global Chronic Wound Care Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product Type
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By End-use
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product Type (USD MN)
  • Advanced Wound Dressing (Foam Dressing, Hydrocolloid Dressing, Film Dressing, Alginate Dressing, Hydrogel Dressing, Collagen Dressing, Other Dressing) Market Sales By Geography (USD MN)
  • Surgical Wound Care (Suture & Staples, Tissue Adhesive & Sealants, Anti-Infective Dressing) Market Sales By Geography (USD MN)
  • Traditional Wound Care (Medical Tapes, Cleansing Agents, Others) Market Sales By Geography (USD MN)
  • Wound Therapy Devices (Negative Pressure Wound Therapy, Oxygen and Hyperbaric Oxygen Equipment, Electric Stimulation Devices, Pressure Relief Devices, Others) Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Diabetic Foot Ulcers Market Sales By Geography (USD MN)
  • Pressure Ulcers Market Sales By Geography (USD MN)
  • Venous Leg Ulcers Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By End-use (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Specialty Clinics Market Sales By Geography (USD MN)
  • Home Healthcare Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR112115301

The global demand for Chronic Wound Care Market is presumed to reach the market size of nearly USD 26.88 Billion by 2032 from USD 17.73 Billion in 2023 with a CAGR of 4.73% under the study period 2024-2032.

Chronic wound care encompasses the therapeutic management of wounds that persist beyond the expected healing time, often due to underlying conditions such as diabetes, vascular diseases, or pressure ulcers. These wounds pose significant challenges as they frequently resist traditional healing methods and require specialized treatments to promote recovery and prevent complications like infections. Effective wound care involves a comprehensive approach tailored to individual patient needs, integrating advanced wound care products, regular monitoring, and often surgical interventions.

MARKET DYNAMICS

The propelling prevalence of chronic conditions such as diabetes, obesity, and cardiovascular diseases worldwide has significantly expanded the patient pool requiring chronic wound management. This demographic shift is expected to escalate demand for advanced wound care products and therapies designed to address the complexities of non-healing wounds. Technological advancements in wound care products, including innovative dressings, bioactive materials, and negative pressure wound therapy systems, are transforming treatment outcomes. These innovations expedite wound healing processes, improve patient comfort, and reduce overall treatment costs, enhancing chronic wound care market adoption. Moreover, the rising awareness among healthcare providers and patients about the benefits of early intervention and comprehensive wound management approaches is driving market expansion. Efforts to educate clinicians on evidence-based wound care practices and the advantages of utilizing advanced wound care technologies are further stimulating chronic wound care market growth. Furthermore, the aging global population presents a significant market opportunity, particularly in developed economies. Elderly individuals are more susceptible to chronic wounds attributed to age-related physiological changes and comorbidities, necessitating specialized wound care solutions customized to their unique needs. However, regulatory challenges and reimbursement issues for advanced wound care products and therapies hinder chronic wound care market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Chronic Wound Care. The growth and trends of Chronic Wound Care industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Chronic Wound Care market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

  • Advanced Wound Dressing (Foam Dressing, Hydrocolloid Dressing, Film Dressing, Alginate Dressing, Hydrogel Dressing, Collagen Dressing, Other Dressing)
  • Surgical Wound Care (Suture & Staples, Tissue Adhesive & Sealants, Anti-Infective Dressing)
  • Traditional Wound Care (Medical Tapes, Cleansing Agents, Others)
  • Wound Therapy Devices (Negative Pressure Wound Therapy, Oxygen and Hyperbaric Oxygen Equipment, Electric Stimulation Devices, Pressure Relief Devices, Others)

By Application

  • Diabetic Foot Ulcers
  • Pressure Ulcers
  • Venous Leg Ulcers
  • Others

By End-use

  • Hospitals
  • Specialty Clinics
  • Home Healthcare
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Chronic Wound Care market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Chronic Wound Care market include Johnson & Johnson, Baxter International, Coloplast Corp., 3M, Medline Industries Inc., ConvaTec Group PLC, Derma Sciences (Integra LifeSciences), MoLnlycke Health Care AB, Paul Hartmann AG, Smith & Nephew PLC. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. CHRONIC WOUND CARE - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product Type
    • 3.7.2 Market Attractiveness Analysis By Application
    • 3.7.3 Market Attractiveness Analysis By End-use
    • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL CHRONIC WOUND CARE MARKET ANALYSIS BY PRODUCT TYPE

  • 5.1. Overview By Product Type
  • 5.2. Historical and Forecast Data Analysis By Product Type
  • 5.3. Advanced Wound Dressing (Foam Dressing, Hydrocolloid Dressing, Film Dressing, Alginate Dressing, Hydrogel Dressing, Collagen Dressing, Other Dressing) Historic and Forecast Sales By Regions
  • 5.4. Surgical Wound Care (Suture & Staples, Tissue Adhesive & Sealants, Anti-Infective Dressing) Historic and Forecast Sales By Regions
  • 5.5. Traditional Wound Care (Medical Tapes, Cleansing Agents, Others) Historic and Forecast Sales By Regions
  • 5.6. Wound Therapy Devices (Negative Pressure Wound Therapy, Oxygen and Hyperbaric Oxygen Equipment, Electric Stimulation Devices, Pressure Relief Devices, Others) Historic and Forecast Sales By Regions

6. GLOBAL CHRONIC WOUND CARE MARKET ANALYSIS BY APPLICATION

  • 6.1. Overview By Application
  • 6.2. Historical and Forecast Data Analysis By Application
  • 6.3. Diabetic Foot Ulcers Historic and Forecast Sales By Regions
  • 6.4. Pressure Ulcers Historic and Forecast Sales By Regions
  • 6.5. Venous Leg Ulcers Historic and Forecast Sales By Regions
  • 6.6. Others Historic and Forecast Sales By Regions

7. GLOBAL CHRONIC WOUND CARE MARKET ANALYSIS BY END-USE

  • 7.1. Overview By End-use
  • 7.2. Historical and Forecast Data Analysis By End-use
  • 7.3. Hospitals Historic and Forecast Sales By Regions
  • 7.4. Specialty Clinics Historic and Forecast Sales By Regions
  • 7.5. Home Healthcare Historic and Forecast Sales By Regions
  • 7.6. Others Historic and Forecast Sales By Regions

8. GLOBAL CHRONIC WOUND CARE MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE CHRONIC WOUND CARE COMPANIES

  • 9.1. Chronic Wound Care Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF CHRONIC WOUND CARE INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Johnson & Johnson
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. Baxter International
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. Coloplast Corp.
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. 3M
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. Medline Industries Inc.
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. ConvaTec Group PLC
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments
  • 10.9. Derma Sciences (Integra LifeSciences)
    • 10.9.1 Company Overview
    • 10.9.2 Company Revenue
    • 10.9.3 Products
    • 10.9.4 Recent Developments
  • 10.10. MoLnlycke Health Care AB
    • 10.10.1 Company Overview
    • 10.10.2 Company Revenue
    • 10.10.3 Products
    • 10.10.4 Recent Developments
  • 10.11. Paul Hartmann AG
    • 10.11.1 Company Overview
    • 10.11.2 Company Revenue
    • 10.11.3 Products
    • 10.11.4 Recent Developments
  • 10.12. Smith & Nephew PLC
    • 10.12.1 Company Overview
    • 10.12.2 Company Revenue
    • 10.12.3 Products
    • 10.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies